MedPath

SENNA S. TABLETS

SENNA S. TABLETS

Approved
DIN Number

02246951

Drug Class

Human

Market Date

Oct 29, 2003

Company
HC

sigma life sciences inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02246951
AIG Number0215780001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A06AB56 SENNA GLYCOSIDES, COMBINATIONS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

DOCUSATE SODIUMActive
Strength: 50 MG
Monograph: DOCUSATE SODIUM
SENNOSIDESActive
Strength: 8.6 MG
Monograph: SENNOSIDES

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.